NANOFORM THERAPEUTICS
Nanoform Therapeutics is develops new generation of Bio-Pharmaceutical developmental or marketed drugs to “first-in-man” demonstration of improved clinical utility when compared to the original versions.
NANOFORM THERAPEUTICS
Industry:
Biotechnology Health Care Medical Medical Device Pharmaceutical
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.nanoformtherapeutics.com
Status:
Active
Contact:
+36-1-577-9300
Email Addresses:
[email protected]
Technology used in webpage:
LetsEncrypt Apache Varnish Varnish 4.x
Official Site Inspections
http://www.nanoformtherapeutics.com
- Host name: alienlabs.hu
- IP address: 185.51.65.164
- Location: Győr Hungary
- Latitude: 47.6833
- Longitude: 17.6351
- Timezone: Europe/Budapest
- Postal: 9021
More informations about "Nanoform Therapeutics"
Organization – Nanoform small is powerful
Our unique approach to drug particle engineering has brought together an ambitious team of scientists with world-renowned experts in pharmaceutical business development. Every …See details»
Nanoform small is powerful
Nov 19, 2024 · Nanoform works to improve the lives of patients globally by overcoming drug development and delivery challenges through our game-changing technologies and novel …See details»
NanoForm Therapeutics - PitchBook
Developer of nano-active pharmaceutical therapies designed to treat serious diseases. The company is developing a proprietary technology called NanoActive, which delivers …See details»
Nanoform Therapeutics - Crunchbase Company Profile & Funding
Nanoform Therapeutics is develops new generation of Bio-Pharmaceutical developmental or marketed drugs to “first-in-man” demonstration of improved clinical utility when compared to …See details»
NanoForm Therapeutics - Products, Competitors, Financials, …
NanoForm Therapeutics is a biotechnology company. It develops nano-active pharmaceutical therapies to treat serious diseases. It provides NanoActive, which delivers improvements in …See details»
Nanoform's biologics technology showcased by large pharma at …
May 30, 2024 · The single-dose, randomized, comparative bioavailability study, performed by a contract research organization in North America, compared enzalutamide 160 mg film-coated …See details»
About Nanoform – Nanoform small is powerful
Our cutting edge nanoforming services is intended to help the global pharmaceutical industry to double its annual new medicines output. We are proud to be a Finnish success story with an …See details»
Nanoform's biologics technology showcased by large pharma at …
May 30, 2024 · Nanoform's CESS ® process uses CO 2 of recycled origin, and is organic hydrocarbon solvent-free, offering a greener alternative to medicine developers that seek to be …See details»
Technologies and services – Nanoform small is powerful
Our nanoforming technologies, formulation and analytical services span the full range of drug development from small-molecule to large-molecule therapeutics. We accelerate your time to …See details»
NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA …
Aug 15, 2024 · Following the completion of in vitro proof of concept studies of a novel plasma-derived therapy formulation, Nanoform will provide non-GMP nanomaterial to Takeda for in …See details»
Nanoform and Takeda team up to advance plasma-derived …
Nanoform, a company specialising in medicine performance-enhancing, has entered into a pre-clinical development partnership with the plasma-derived therapy unit of Takeda …See details»
Nanoform’s final clinical results confirm value proposition to the ...
May 18, 2021 · Nanoform has now received the final clinical study report on the pharmacokinetic (PK) study results related to its Phase 1, single-center, part crossover, open-label, partially …See details»
Nanoform Q3 2023: Nanoformed blockbuster drug enters clinic
Nov 22, 2023 · Nanoform Q3 2023: Nanoformed blockbuster drug enters clinic and another nanoformed drug received FDA orphan designation. Project Blockbuster is progressing well. …See details»
Nano-Based Approved Pharmaceuticals for Cancer Treatment: …
Nanotechnology, through the development of nanoscale-based pharmaceuticals, has emerged to provide new and innovative drugs to overcome these limitations. In this review, we provide an …See details»
Vision, mission and values – Nanoform small is powerful
Our mission is to support pharma companies as they develop life-changing medicines, by overcoming drug development & delivery challenges. We will help the global pharma industry …See details»
Nanoscope Therapeutics
Nanoscope is focused on proprietary ambient light activated optogenetic therapy to restore vision in people suffering from all forms of Retinitis Pigmentosa, Stargardt and other inherited retinal …See details»
Nanoform and Celanese Expand Collaboration into Long-Acting …
Sep 5, 2024 · Helsinki, Finland & Dallas, US – September 5, 2024 – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, and Celanese …See details»
Report of the Board of Directors and Financial Statements
Leveraging each organization’s unique formulation exper-tise. On June 2, Nanoform raised its mid-term business tar-gets for 2025. The new targets are: • To nanoform annually at least 70 new …See details»
Nanoform launches technology for biologics and sets new near …
Nov 27, 2020 · Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in …See details»
Nanoform and Celanese Demonstrate Enhanced Drug Delivery …
Jun 15, 2023 · Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform …See details»